Abstract
Refractory angina is defined as persistent angina (≥3 months) despite optimal medical and interventional therapies. It is increasing in frequency, due to the success of current medical and interventional therapies in improving the prognosis of coronary artery disease. Long‐term mortality is similar to that of patients with asymptomatic stable disease, but it affects patients’ quality of life, and has a significant impact on health care resources. Several therapeutic targets have been investigated, most with disappointing results. Many of the techniques have been abandoned because of lack of efficacy, safety issues, or economic and logistic limitations to wider applicability. The primary focus of this review is the coronary sinus Reducer, supporting evidence for which, although scarce, is promising regarding safety and efficacy in improving anginal symptoms and quality of life. It is also accessible to virtually all interventional cardiology departments.
| Translated title of the contribution | Non‐pharmacological treatment of refractory angina: the coronary sinus reducer, the new kid on the block |
|---|---|
| Original language | Portuguese |
| Pages (from-to) | 371-382 |
| Number of pages | 12 |
| Journal | Revista Portuguesa de Cardiologia |
| Volume | 40 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - May 2021 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Coronary sinus reducer device
- Non‐pharmacological antianginal therapy
- Refractory angina
- Coronary artery disease
Fingerprint
Dive into the research topics of 'Non‐pharmacological treatment of refractory angina: the coronary sinus reducer, the new kid on the block'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver